A member of the advanced prostate cancer on-line support group who is the wife of an advanced prostate cancer survivor in New Mexico just informed us that Trailblazer (the MAC that controls New Mexico reimbursements for Medicare and Medicaid) has said they will not pay for her husband to get Provenge. They were also told by their doctor that he can’t get Medicare/Trailblazer to pay for Jevtana even though he meets the FDA approved label for failed chemotherapy.

She posted: “Jevtana for prostate cancer, Medicare doesn’t want to pay for it. We also learned today that Provenge will not be covered by Medicare & we will have to pay cash for it.
Die or use up all your retirement savings.”

She is very upset as these were his last treatment options that have demonstrated any survival advantage.

Both Provenge and Jevtana have been approved by the FDA.

This is outrageous.

Joel T Nowak, M.A., M.S.W.